Skip to main content

Table 1 Schedule of events

From: Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol

Time point

Study period

Enrolment

Post enrolment

-4 weeks

Baseline

13th week

26th week

39th week

52nd week

65th week

Enrolment

Screening

             √

      

Informed consent

             √

      

Medical history

             √

      

Kardia provision

             √

      

Intervention

Liraglutide

 

Daily injections

Assessments

BMI check

 

           √

            √

   

            √

Blood tests

 

           √

            √

    

CMR

 

           √

            √

    

Right atrial mapping

 

           √

            √

    

AF ablation

  

            √

    

Review on Kardia recordings

   

            √

            √

             √

            √

AFEQT

 

           √

            √

   

            √